Publications (153) Publications auxquelles un chercheur a participé

2021

  1. 3D voxel-based dosimetry to predict contralateral hypertrophy and an adequate future liver remnant after lobar radioembolization

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, Núm. 10, pp. 3048-3057

  2. A Mediterranean lifestyle reduces the risk of cardiovascular disease in the “Seguimiento Universidad de Navarra” (SUN) cohort

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 31, Núm. 6, pp. 1728-1737

  3. A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCC

    Hepatology Communications, Vol. 5, Núm. 3, pp. 538-547

  4. A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia

    Journal of Clinical Investigation, Vol. 131, Núm. 20

  5. A proof-of-concept study of the in-vivo validation of a computational fluid dynamics model of personalized radioembolization

    Scientific Reports, Vol. 11, Núm. 1

  6. A proteomic atlas of lineage and cancer-polarized expression modules in myeloid cells modeling immunosuppressive tumor-infiltrating subsets

    Journal of Personalized Medicine, Vol. 11, Núm. 6

  7. A small virus to deliver small antibodies: New targeted therapies based on AAV delivery of nanobodies

    Microorganisms, Vol. 9, Núm. 9

  8. Aav-hdv: An attractive platform for the in vivo study of hdv biology and the mechanism of disease pathogenesis

    Viruses, Vol. 13, Núm. 5

  9. Abnormal liver function test in patients infected with coronavirus (Sars-cov-2): A retrospective single-center study from spain

    Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-18

  10. Acquiring sepsis competencies through simulation-based learning bundle during intermediate care unit internship

    Medicine, Vol. 100, Núm. 5, pp. e24483

  11. Adenovirus-mediated inducible expression of a pd-l1 blocking antibody in combination with macrophage depletion improves survival in a mouse model of peritoneal carcinomatosis

    International Journal of Molecular Sciences, Vol. 22, Núm. 8

  12. AdrA as a Potential Immunomodulatory Candidate for STING-Mediated Antiviral Therapy That Required Both Type I IFN and TNF-α Production

    Journal of immunology (Baltimore, Md. : 1950), Vol. 206, Núm. 2, pp. 376-385

  13. Advances in immunotherapy for hepatocellular carcinoma

    Nature Reviews Gastroenterology and Hepatology, Vol. 18, Núm. 8, pp. 525-543

  14. Alcoholic Hepatitis

    Clinical Liver Disease, Vol. 18, Núm. 2, pp. 90-95

  15. Alcoholic-related liver disease: Pathogenesis, management and future therapeutic developments

    Revista Espanola de Enfermedades Digestivas, Vol. 112, Núm. 11, pp. 869-878

  16. An Experimental DUAL Model of Advanced Liver Damage

    Hepatology Communications, Vol. 5, Núm. 6, pp. 1051-1068

  17. Armcx3 mediates susceptibility to hepatic tumorigenesis promoted by dietary lipotoxicity

    Cancers, Vol. 13, Núm. 5, pp. 1-22

  18. Assessing the impact of COVID-19 on liver cancer management (CERO-19)

    JHEP Reports, Vol. 3, Núm. 3

  19. Association of sdf1 and mmp12 with atherosclerosis and inflammation: Clinical and experimental study

    Life, Vol. 11, Núm. 5

  20. Astrocytic GLUT1 ablation improves systemic glucose metabolism and promotes cognition

    Alzheimer's & dementia : the journal of the Alzheimer's Association, Vol. 17, pp. e058650